[1]Patent:WO2017/60854,2017,A1.Locationinpatent:Page/Pagecolumn171
[2]JournalofMedicinalChemistry,2021,vol.64,p.15949-15972
405879-09-6
102-82-9
13028-69-8
1643-19-2
20193-21-9
2052-49-5
1315365-45-7 | methyl 4-bromo-5-formyl-1-methyl-1H-pyrrole-2-carboxylate | AA01AIW4 | MFCD19381978
1096852-39-9 | N-[(2,5-Difluorophenyl)methyl]aniline | AA01AJ2Z | MFCD11639633
1315369-01-7 | 4-[1-(difluoromethyl)-1H-imidazol-2-yl]aniline | AA01AJ8X | MFCD17245639
1315365-13-9 | 1-(pyridazin-3-yl)-1,4-diazepane dihydrobromide | AA01AJEP | MFCD19382297
1343146-15-5 | 2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-2-methylpentanoic acid | AA01AJJ8 | MFCD18263425
89793-51-1 | 3-(4-chlorothiophen-2-yl)propanoic acid | AA01AJOT | MFCD18324747
1333695-19-4 | 2,2-dimethyl-3-(2-methylpropoxy)cyclobutan-1-ol | AA01AJU9 | MFCD14612914
946774-01-2 | 2-[2-(dimethylamino)ethoxy]-4-methylaniline | AA01AK0M | MFCD08687604
1017459-30-1 | 5-amino-N-tert-butyl-2-methylbenzene-1-sulfonamide | AA01AK6F | MFCD11133822
1333993-35-3 | N-(4-aminophenyl)butane-1-sulfonamide hydrochloride | AA01AKBP | MFCD19982555